Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08276 | 32171530 | Biochem Biophys Res Commun | Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway. | 2020 | Details |
| A08285 | 32169430 | Gastroenterology | Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet. | 2020 | Details |
| A08286 | 32169417 | Biochem Pharmacol | Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A08296 | 32165250 | J Hepatol | Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. | 2020 | Details |
| A08298 | 32163832 | J Nutr Biochem | Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver. | 2020 | Details |
| A08299 | 32161549 | Front Pharmacol | Relationship Between Ginsenoside Rg3 and Metabolic Syndrome. | 2020 | Details |
| A08300 | 32161545 | Front Pharmacol | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities. | 2020 | Details |
| A08309 | 32158242 | Diabetes Metab Syndr Obes | DHA Protects Against Hepatic Steatosis by Activating Sirt1 in a High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model. | 2020 | Details |
| A08311 | 32157523 | Obes Surg | Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds. | 2020 | Details |
| A08313 | 32156377 | Food Res Int | Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice. | 2019 | Details |
| A08315 | 32156140 | Ann Palliat Med | Association between non-alcoholic fatty liver disease and silent carotid plaque in Chinese aged population: a cross-sectional study. | 2020 | Details |
| A08317 | 32154399 | Heliyon | The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. | 2020 | Details |
| A08318 | 32153507 | Front Endocrinol (Lausanne) | Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review. | 2020 | Details |
| A08321 | 32152903 | Indian J Gastroenterol | Epidemiology of non-alcoholic fatty liver disease in Asia. | 2020 | Details |
| A08322 | 32152902 | Indian J Gastroenterol | Treatment of non-alcoholic fatty liver disease - Current perspectives. | 2020 | Details |
| A08323 | 32152677 | Surg Endosc | Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis. | 2020 | Details |
| A08325 | 32152478 | Nat Rev Gastroenterol Hepatol | Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. | 2020 | Details |
| A08326 | 32151955 | Int Immunopharmacol | Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways. | 2020 | Details |
| A08328 | 32151552 | Surg Obes Relat Dis | Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons. | 2020 | Details |
| A08330 | 32150756 | Hepatology | N6 -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes. | 2020 | Details |
| A08332 | 32150108 | Medicine (Baltimore) | Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial. | 2020 | Details |
| A08336 | 32149275 | JHEP Rep | Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. | 2019 | Details |
| A08339 | 32148405 | J Ginseng Res | Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice. | 2018 | Details |
| A08341 | 32147363 | J Hepatol | Newly identified peptide hormone inhibits intestinal fat absorption and improves NAFLD through its receptor GPRC6A. | 2020 | Details |
| A08343 | 32147361 | J Hepatol | Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. | 2020 | Details |
| A08351 | 32145387 | Prostaglandins Other Lipid Mediat | Lipocalin-type prostaglandin D2 synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease. | 2020 | Details |
| A08353 | 32145306 | Life Sci | Differential metabolic and hepatic transcriptome responses of two miniature pig breeds to high dietary cholesterol. | 2020 | Details |
| A08357 | 32145139 | BJOG | Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study. | 2020 | Details |
| A08360 | 32144313 | Sci Rep | Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation. | 2020 | Details |
| A08361 | 32143931 | J Pediatr | Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study. | 2020 | Details |
| A08365 | 32143076 | Chemosphere | Differential mechanisms regarding triclosan vs. bisphenol A and fluorene-9-bisphenol induced zebrafish lipid-metabolism disorders by RNA-Seq. | 2020 | Details |
| A08366 | 32142998 | Diabetes Metab Syndr | rs7903146 (C/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians. | 2020 | Details |
| A08368 | 32141825 | Turk J Gastroenterol | Analysis of correlation between liver fat fraction and AST and ALT levels in overweight and obese children by using new magnetic resonance imaging technique. | 2020 | Details |
| A08379 | 32135178 | J Hepatol | Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis. | 2020 | Details |
| A08381 | 32133676 | Aliment Pharmacol Ther | Modelling NAFLD disease burden in four Asian regions-2019-2030. | 2020 | Details |
| A08385 | 32130675 | Hepatol Int | The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. | 2020 | Details |
| A08389 | 32129747 | Med Sci (Paris) | [Endoplasmic reticulum stress response and pathogenesis of non-alcoholic steatohepatitis]. | 2020 | Details |
| A08390 | 32128995 | Pediatr Obes | Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial. | 2020 | Details |
| A08400 | 32124690 | Curr Pharm Des | Epidemiology of Non-alcoholic Fatty Liver Disease in North America. | 2020 | Details |
| A08404 | 32124221 | Obes Surg | Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass? | 2020 | Details |
| A08405 | 32124219 | Obes Surg | Obstructive Sleep Apnea and Non-alcoholic Fatty Liver Disease in Obese Patients Undergoing Bariatric Surgery. | 2020 | Details |
| A08406 | 32124215 | Obes Surg | Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity. | 2020 | Details |
| A08407 | 32124212 | Obes Surg | Evaluation of Liver Function Tests and Risk Score Assessment to Screen Patients for Significant Liver Disease Prior to Bariatric and Metabolic Surgery. | 2020 | Details |
| A08425 | 32116145 | RNA Biol | GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs. | 2020 | Details |
| A08429 | 32114355 | Biomed Pharmacother | Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed rats. | 2020 | Details |
| A08430 | 32113842 | Bioorg Med Chem Lett | Anilinopyrazines as potential mitochondrial uncouplers. | 2020 | Details |
| A08432 | 32113467 | Lipids Health Dis | Differential effects of Chinese high-fat dietary habits on lipid metabolism: mechanisms and health implications. | 2020 | Details |
| A08433 | 32112699 | Horm Mol Biol Clin Investig | Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms. | 2020 | Details |
| A08440 | 32110378 | Cell Biosci | RNA N6-methyladenosine: a promising molecular target in metabolic diseases. | 2020 | Details |
| A08450 | 32105829 | Free Radic Biol Med | 17β-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance. | 2020 | Details |
| A08452 | 32105577 | Circ Res | Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. | 2020 | Details |
| A08453 | 32105003 | Turk J Pediatr | Cardiometabolic risk factors in Turkish children with hepatosteatosis. | 2019 | Details |
| A08459 | 32103741 | BMC Gastroenterol | Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08460 | 32103588 | Mol Nutr Food Res | Regulation of Adipocyte and Macrophage Functions by mTORC1 and 2 in Metabolic Diseases. | 2020 | Details |
| A08461 | 32102936 | Sci Transl Med | Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance. | 2020 | Details |
| A08462 | 32102237 | Int J Mol Sci | Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. | 2020 | Details |
| A08465 | 32100496 | Zhongguo Zhen Jiu | [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial]. | 2020 | Details |
| A08468 | 32099613 | Gastroenterol Hepatol Bed Bench | Effects of high fat medium conditions on cellular gene expression profile: a network analysis approach. | 2019 | Details |
| A08470 | 32097572 | Annu Rev Clin Psychol | Prevention and Management of Childhood Obesity and Its Psychological and Health Comorbidities. | 2020 | Details |
| A08471 | 32097065 | Br J Hosp Med (Lond) | Detecting chronic liver disease: are liver function tests the solution? | 2020 | Details |
| A08477 | 32095253 | BMJ Open Gastroenterol | Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). | 2020 | Details |
| A08480 | 32093016 | Cells | The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. | 2020 | Details |
| A08481 | 32092940 | Nutrients | Programming Skeletal Muscle Metabolic Flexibility in Offspring of Male Rats in Response to Maternal Consumption of Slow Digesting Carbohydrates during Pregnancy. | 2020 | Details |
| A08482 | 32092735 | Biomed Res | Placental extract ameliorates liver fibrosis in a methionine- and choline-deficient diet-induced mouse model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08484 | 32092046 | Eur J Gastroenterol Hepatol | Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients. | 2020 | Details |
| A08486 | 32091437 | Eur J Gastroenterol Hepatol | MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A08487 | 32090434 | Liver Int | Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA. | 2020 | Details |
| A08494 | 32087002 | Liver Int | The association between etiology of hepatocellular carcinoma and race-ethnicity in Florida. | 2020 | Details |
| A08497 | 32086249 | Biol Open | Long-term sucrose solution consumption causes metabolic alterations and affects hepatic oxidative stress in Wistar rats. | 2020 | Details |
| A08506 | 32083190 | Biochem Biophys Rep | Short-term high-fat diet intake leads to exacerbation of concanavalin A-induced liver injury through the induction of procoagulation state. | 2020 | Details |
| A08510 | 32081727 | Mitochondrion | Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome. | 2020 | Details |
| A08511 | 32081018 | Rev Esp Enferm Dig | Mechanism of bariatric and metabolic surgery: beyond surgeons, gastroenterologists and endocrinologists. | 2020 | Details |
| A08513 | 32077785 | Metab Syndr Relat Disord | Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases. | 2020 | Details |
| A08519 | 32077608 | Liver Int | Natural history of NASH and HCC. | 2020 | Details |
| A08521 | 32075973 | Nat Commun | Alterations in promoter interaction landscape and transcriptional network underlying metabolic adaptation to diet. | 2020 | Details |
| A08528 | 32073443 | Eur J Gastroenterol Hepatol | The association of nonalcoholic steatohepatitis and hepatocellular carcinoma. | 2020 | Details |
| A08534 | 32069845 | Int J Mol Sci | Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer. | 2020 | Details |
| A08535 | 32069503 | Semin Liver Dis | Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions. | 2020 | Details |
| A08541 | 32067588 | J Am Heart Assoc | Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study. | 2020 | Details |
| A08545 | 32066623 | Gut | Advances in non-invasive assessment of hepatic fibrosis. | 2020 | Details |
| A08549 | 32064966 | Expert Rev Gastroenterol Hepatol | Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice. | 2020 | Details |
| A08551 | 32064187 | Cureus | Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08553 | 32063504 | Ann Hepatol | Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening? | 2020 | Details |
| A08558 | 32061598 | Gastroenterology | Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08561 | 32061595 | Gastroenterology | Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. | 2020 | Details |
| A08562 | 32061583 | Obes Res Clin Pract | Elevated 1-h post-load plasma glucose levels in normal glucose tolerance children with obesity is associated with early carotid atherosclerosis. | 2020 | Details |
| A08566 | 32059982 | J Hepatol | NAFLD as a driver of chronic kidney disease. | 2020 | Details |
| A08567 | 32058943 | EBioMedicine | Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes. | 2020 | Details |
| A08569 | 32058041 | J Proteomics | Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease. | 2020 | Details |
| A08577 | 32054379 | J Recept Signal Transduct Res | Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A08580 | 32053033 | Expert Opin Ther Targets | Emerging therapeutic targets for NASH: key innovations at the preclinical level. | 2020 | Details |
| A08583 | 32051143 | J Biol Chem | Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease. | 2020 | Details |
| A08584 | 32051092 | Eur J Intern Med | NAFLD and autoimmune hepatitis: Do not judge a book by its cover. | 2020 | Details |
| A08585 | 32050765 | J Agric Food Chem | Theaflavin TF3 Relieves Hepatocyte Lipid Deposition through Activating an AMPK Signaling Pathway by targeting Plasma Kallikrein. | 2020 | Details |
| A08587 | 32049637 | BMJ Open Diabetes Res Care | Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. | 2020 | Details |
| A08588 | 32048436 | Obes Rev | Foetal and childhood exposure to famine and the risks of cardiometabolic conditions in adulthood: A systematic review and meta-analysis of observational studies. | 2020 | Details |
| A08589 | 32048317 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease burden: Australia, 2019-2030. | 2020 | Details |
| A08590 | 32048152 | Obes Surg | Alterations in the Liver Fat Fraction Features Examined by Magnetic Resonance Imaging Following Bariatric Surgery: a Self-Controlled Observational Study. | 2020 | Details |
| A08596 | 32045588 | Toxicol Appl Pharmacol | Orlistat delays hepatocarcinogenesis in mice with hepatic co-activation of AKT and c-Met. | 2020 | Details |
| A08597 | 32045507 | Mol Nutr Food Res | Lactose, Maltose, and Sucrose in Health and Disease. | 2020 | Details |